Laboratorios Farmaceuticos Rovi SA

41L

Company Profile

  • Business description

    Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.

  • Contact

    Julian Camarillo, 35
    Madrid28037
    ESP

    T: +34 913756230

    E: [email protected]

    https://www.rovi.es

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,188

Stocks News & Analysis

stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.
stocks

Undervalued ASX share searches for cost savings

Cost savings from recent acquisition underpin our earnings growth forecasts.
stocks

Chart of the Week: Where we see opportunities after year end market sell-off

The latest insights from our equity research team.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,983.3028.900.32%
CAC 408,068.6217.14-0.21%
DAX 4024,287.996.62-0.03%
Dow JONES (US)48,531.41172.60-0.35%
FTSE 1009,649.0354.13-0.56%
HKSE25,976.79446.281.75%
NASDAQ23,255.29338.56-1.43%
Nikkei 22550,836.55687.731.37%
NZX 50 Index13,406.9111.040.08%
S&P 5006,837.1863.82-0.92%
S&P/ASX 2008,697.3032.400.37%
SSE Composite Index3,889.3516.030.41%

Market Movers